Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy for multiple myeloma]

A Togawa1

  • 1Division of Internal Medicine, International Medical Center of Japan.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1995
PubMed
Summary

Melphalan improved myeloma treatment, but combination therapies show no added benefit. Intensifying treatment with stem cell support may further reduce tumor mass and extend survival in myeloma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of earlier intervention by an antimicrobial stewardship team for specific antimicrobials in a single weekly intervention.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2018
Same author

Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells.

Oncogene·2007
Same author

Isolation and characterization of native Cry j 3 from Japanese cedar (Cryptomeria japonica) pollen.

Allergy·2007
Same author

RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells.

Biochemical and biophysical research communications·2006
Same author

Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.

Kidney international·2006
Same author

[Experiment to establish the therapeutic dosage and administration term of macrolide antibiotics using the Explant Culture Method for human nasal mucosa].

The Japanese journal of antibiotics·2003

Area of Science:

  • Oncology
  • Hematology
  • Pharmacology

Context:

  • Melphalan (MP) is a cornerstone in multiple myeloma treatment, improving remission rates and survival.
  • Combination chemotherapy regimens have been explored to enhance MP therapy outcomes.
  • Previous studies suggest limited additional efficacy of combination chemotherapy over MP alone.

Purpose:

  • To evaluate the efficacy of combination chemotherapy against standard melphalan (MP) therapy for multiple myeloma.
  • To assess the impact of intensified therapy, including bone marrow ablative therapy with stem cell support, on myeloma treatment outcomes.

Summary:

  • While melphalan has improved outcomes, attempts to enhance its efficacy through combination chemotherapy have not demonstrated significant differences compared to MP therapy alone.
  • Intensified treatment strategies, specifically bone marrow ablative therapy with stem cell support, show promise in reducing tumor burden.
  • Evidence suggests that further intensification of therapy may lead to greater tumor-mass reduction and prolonged survival times in multiple myeloma patients.

Impact:

  • The findings question the routine use of combination chemotherapy for multiple myeloma, suggesting a potential plateau in efficacy with current non-intensive approaches.
  • Highlights the potential of high-dose therapy and autologous stem cell transplantation (ASCT) in achieving deeper responses and improving survival.
  • Provides a rationale for further research into novel intensified treatment strategies for multiple myeloma to overcome treatment resistance and improve long-term outcomes.

Related Experiment Videos